FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Noven Pharmaceuticals Estradiol Transdermal System Delivers 0 Recall

Estradiol Transdermal System Delivers 0

Noven Pharmaceuticals Inc · Miami, FL

Risk level
Class II
Reported by FDA
Apr 28, 2021
Recall ID
D-0337-2021
Check your lot numberHow we source this data

Summary

Noven Pharmaceuticals recalled Estradiol Transdermal System Delivers 0 starting Apr 16, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0337-2021 on Apr 28, 2021. Reason: Defective Delivery System: Out of specification for release rate testing and shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin. Status: Terminated.

Why it was recalled

Defective Delivery System: Out of specification for release rate testing and shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin.

Product description

Estradiol Transdermal System Delivers 0.0375 mg/day, 8 Systems/box, Rx only, Mfd. by: Noven Pharmaceuticals, Inc. Miami, Florida 33186 Dist. by: Noven Therapeutics, LLC Miami, Florida 33186, NDC 68968-3437-8

Lot numbers, UPCs & expiration codes

Lot #: 88321 Exp. 02/2022

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0337-2021
Classification
Class II
Status
Terminated
Recall initiated
Apr 16, 2021
FDA report date
Apr 28, 2021
Quantity
10872 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Noven Pharmaceuticals Inc

Original FDA data

Every field from FDA enforcement report D-0337-2021, exactly as published.

Show all FDA fields
City
Miami
State
FL
Status
Terminated
Country
United States
Event ID
87741
Address
11960 Sw 144th St
Code information
Lot #: 88321 Exp. 02/2022
Postal code
33186-6109
Report date
Apr 28, 2021
Product type
Drugs
Recall number
D-0337-2021
Classification
Class II
Recalling firm
Noven Pharmaceuticals Inc
Product quantity
10872 cartons
Termination date
Oct 11, 2024
Reason for recall
Defective Delivery System: Out of specification for release rate testing and shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Estradiol Transdermal System Delivers 0.0375 mg/day, 8 Systems/box, Rx only, Mfd. by: Noven Pharmaceuticals, Inc. Miami, Florida 33186 Dist. by: Noven Therapeutics, LLC Miami, Florida 33186, NDC 68968-3437-8
Distribution pattern
Nationwide within the United States
Recall initiation date
Apr 16, 2021
Initial firm notification
Letter
Center classification date
Apr 20, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0337-2021, published Apr 28, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls